confounding factors on the effect of intravitreal triamcinolone for refractory diabetic macular edema
نویسندگان
چکیده
purpose: to evaluate the influence of different confounding factors on the effect of intravitreal triamcinolone acetonide injection for refractory diabetic macular edema. methods: in a prospective placebo-controlled randomized clinical trial, 88 eyes with refractory diabetic macular edema were randomly assigned into two groups including 45 in the treatment group (4 mg intravitreal triamcinolone acetonide) and 43 in the placebo group. multivariate analysis was performed for three main outcomes, including visual acuity, central macular thickness, and the amount of hard exudates. confounding factors that showed some effect on the main outcomes were used for building multivariate models. results: it was revealed that blood urea nitrogen, fasting blood sugar, serum cholesterol, initial visual acuity, presence of cystoid macular edema, amount of hard exudates, and size of foveal avascular zone had some influence on visual acuity outcome; previous macular photocoagulation, serum cholesterol, baseline central macular thickness, initial intraocular pressure, amount of hard exudates, and size of foveal avascular zone had some influence on central macular thickness changes; and serum cholesterol, baseline central macular thickness, and amount of hard exudates had some influence on hard exudates in both groups. size of foveal avascular zone, initial intraocular pressure, amount of hard exudates, and baseline central macular thickness also had an additive effect on the outcomes in the treatment group. conclusions: many confounding factors may influence the effect of intravitreal triamcinolone. these factors should be considered when adopting intravitreal triamcinolone as a treatment strategy for refractory diabetic macular edema.
منابع مشابه
intravitreal triamcinolone for treatment of refractory diabetic macular edema
purpose: to determine if intravitreal injection of triamcinolone acetonide is safe and effective in the treatment of diabetic macular edema unresponsive to prior laser photocoagulation. methods: fifty-four eyes of 38 patients with clinically significant macular edema which had received at least two sessions of laser photocoagulation according to early treatment diabetic retinopathy study guidel...
متن کاملIntravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
PURPOSE To evaluate the effect of intravitreal triamcinolone acetonide (IVT) reinjection on clinical and optical coherence tomographic features in refractory diabetic macular edema. METHODS In a prospective interventional case series, all IVT treated patients enrolled in a previous clinical trial were recalled to have a new ophthalmologic examination and optical coherence tomography (OCT) per...
متن کاملreinjection of intravitreal triamcinolone for refractory diabetic macular edema
purpose: to evaluate the effect of intravitreal triamcinolone acetonide (ivt) reinjection on clinical and optical coherence tomographic (oct) features in refractory diabetic macular edema (dme). methods: in an interventional case series, all ivt-treated patients enrolled in a previous clinical trial (45 subjects), were recalled for performing a new ophthalmologic examination and oct. suitable e...
متن کاملEffect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection
PURPOSE To evaluate the effects of posterior subtenon triamcinolone acetonide injection on refractory diabetic macular edema (DME) after intravitreal bevacizumab (IVB) injection failure. METHODS Patients with DME and central subfield thickness (CST) >300 µm who did not respond to IVB injections were retrospectively included. Specifically, we enrolled patients who were diagnosed with refractor...
متن کاملIntravitreal Triamcinolone Acetonide for Diabetic Macular Edema Refractory to Intravitreal Ranibizumab. Nine-month Results
The Purpose of this study was to evaluate the efficacy of IVTA as rescue therapy in patients with DME refractory to intravitreal ranibizumab. This is a prospective interventional non-comparative study that included diabetic patients with persistent CSME and associated visual loss despite previous treatment with intravitreal ranibizumab. Main outcome measures were improvement of BCVA 3 Snellen l...
متن کاملIntravitreal injection of triamcinolone for diffuse diabetic macular edema.
OBJECTIVE To evaluate the clinical outcome of an intravitreal injection of triamcinolone acetonide as treatment of diffuse diabetic macular edema. PARTICIPANTS This prospective, interventional, clinical case series study included 20 patients (26 eyes) who received an intravitreal injection of 25 mg of triamcinolone acetonide for treatment of diffuse diabetic macular edema. Mean +/- SD follow-...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
بیناجلد ۱۱، شماره ۲، صفحات ۱۶۴-۱۷۵
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023